Amid Ukraine-Russia crisis, our analysts and industry experts are closely monitoring the markets and working hard to identify, gather and timely deliver analysis of the impact of the situation and the impact that it has on various markets. All our reports are updated with the latest impact on the market before being sent out to our customers.

Global Viral Inactivation Market: By Product: Kits and Reagents, Systems, Services; By Application: Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Others; By End-use; Regional Analysis; Historical Market and Forecast (2017-2027); Market Dynamics; Competitive Landscape; Industry Events and Developments

Global Viral Inactivation Market Outlook

The global viral inactivation market reached a value of about USD 552.33 million in 2021. The industry is further expected to grow at a CAGR of 11.50% in the forecast period of 2022-2027 to reach a value of around USD 1061.33 million by 2027.

 

Global Viral Inactivation Market

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

North America to be a Significant Regional Market for Viral Inactivation

North America is expected to account for a considerable share of the viral inactivation industry. This can be attributed to the robust healthcare infrastructure, and the presence of large pharmaceutical and biopharmaceutical companies. The increasing healthcare research and development (R&D) spending by the United States government is expected to fuel the market in North America. The robust growth of the pharmaceuticals industry, the surging approvals of novel drugs, and the rising penetration of research and academic institutes that promote biotechnology and life science research activities are projected to boost the growth of the viral inactivation industry. Moreover, the increasing use of technologically advanced processes for the production of new and novel drugs is anticipated to bolster the market for viral inactivation in the forecast period.

The viral inactivation industry in Europe is witnessing robust growth due to the increasing spending on research and development (R&D) activities and new product releases in the life sciences industry. Meanwhile, due to the expanding healthcare infrastructure, the Asia Pacific region is predicted to grow rapidly. The increasing prevalence of chronic diseases in developing economies like India and China and the growing interests in life sciences and biotechnology research activities are estimated to invigorate the viral inactivation industry in the coming years.

 

Viral Inactivation: Market Segmentation

Viral inactivation is a method of viral elimination in which the viruses are removed but remain non-infectious in the finished product. The inactivation of viruses is a crucial step in the viral clearance process. Viral inactivation is integral in the manufacturing of biological goods such as tissue and tissue products, stem cell products, vaccines and medicines, among others.

 

Global Viral Inactivation Market By Segment

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

By product, the market is divided into:

  • Kits and Reagents
  • Systems
  • Services

The significant applications of viral inactivation are:

  • Vaccines and Therapeutics
  • Stem Cell Products
  • Blood and Blood Products
  • Tissue and Tissue Products
  • Cellular and Gene Therapy

The various end-uses of viral inactivation in the market are:

  • Pharmaceutical and Biotechnology Companies
  • CROs
  • Academic and Research Institutes
  • Others

The EMR report looks into the regional markets of viral inactivation like into North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa.

 

Global Viral Inactivation Market By Region

Read more about this report - REQUEST FREE SAMPLE COPY IN PDF

 

Rising Prevalence of Chronic Diseases to Augment the Market Growth of Viral Inactivation

The rising prevalence of chronic diseases such as cancer, autoimmune disorders, and other diseases, and rising healthcare expenditures are driving the viral inactivation industry. The market is also being propelled by the rapid growth of the pharmaceutical and biotechnology industries, and the increasing launches of novel medication. Various governments are increasingly introducing favourable initiatives to support and fund viral inactivation research activities to prevent viral outbreaks, especially in the wake of the COVID-19 pandemic. With the growing concerns regarding the transmission of blood-borne viruses through plasma-derived medical goods, the demand for effective viral inactivation is significantly surging and driving the market growth.

The increasing investments in research and development (R&D) activities for the development of innovative therapeutics in the life science industry is leading to a surge in the use of kits and reagents, which is invigorating the market growth. Advancements in nano filtration technology are surging the demand for viral inactivation for efficient viral elimination in the manufacturing of biopharmaceutical drugs, therefore adding to the market growth. Furthermore, the increased research and development (R&D) activities for innovations in stem cell and cellular and gene therapy are expected to provide lucrative growth opportunities for the market expansion in the forecast period.

 

Key Industry Players in the Global Viral Inactivation Market

The report gives a detailed analysis of the following key players in the global viral inactivation market, covering their competitive landscape, capacity, and latest developments like mergers, acquisitions, and investments, expansions of capacity, and plant turnarounds:

  • Rad Source Technologies Inc
  • Merck KGaA
  • Parker Hannifin Corp
  • Sartorius AG
  • Cerus Corporation
  • Others

The comprehensive EMR report provides an in-depth assessment of the market based on the Porter's five forces model along with giving a SWOT analysis.

 

REPORT FEATURES DETAILS
Base Year 2021
Historical Period 2017-2021
Forecast Period 2022-2027
Scope of the Report Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment- Product, Application, End-use, Region
Breakup by Product Kits and Reagents, Systems, Services
Breakup by Application Vaccines and Therapeutics, Stem Cell Products, Blood and Blood Products, Tissue and Tissue Products, Cellular and Gene Therapy
Breakup by End-use Pharmaceutical and Biotechnology Companies, CROs, Academic and Research Institutes, Others
Breakup by Region North America, Europe, Asia Pacific, Latin America, Middle East and Africa
Market Dynamics SWOT, Porter's Five Forces, Key Indicators for Price and Demand
Competitive Landscape Market Structure, Company Profiles- Company Overview, Product Portfolio, Demographic Reach and Achievements, Certifications
Companies Covered Rad Source Technologies Inc, Merck KGaA, Parker Hannifin Corp, Sartorius AG, Cerus Corporation, Others
Report Price and Purchase Option Explore our purchase options that are best suited to your resources and industry needs.
Delivery Format Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option.

 

*We at Expert Market Research always strive to give you the latest information. The numbers in the article are only indicative and may be different from the actual report.

1    Preface    
2    Report Coverage – Key Segmentation and Scope
3    Report Description

    3.1    Market Definition and Outlook
    3.2    Properties and Applications
    3.3    Market Analysis
    3.4    Key Players
4    Key Assumptions
5    Executive Summary

    5.1    Overview
    5.2    Key Drivers
    5.3    Key Developments
    5.4    Competitive Structure
    5.5    Key Industrial Trends
6    Snapshot
    6.1    Global
    6.2    Regional
7    Industry Opportunities and Challenges
8    Global Viral Inactivation Market Analysis

    8.1    Key Industry Highlights
    8.2    Global Viral Inactivation Historical Market (2017-2021) 
    8.3    Global Viral Inactivation Market Forecast (2022-2027)
    8.4    Global Viral Inactivation Market by Product
        8.4.1    Kits and Reagents
            8.4.1.1    Market Share
            8.4.1.2    Historical Trend (2017-2021)
            8.4.1.3    Forecast Trend (2022-2027)
        8.4.2    Systems
            8.4.2.1    Market Share
            8.4.2.2    Historical Trend (2017-2021)
            8.4.2.3    Forecast Trend (2022-2027)
        8.4.3    Services
            8.4.3.1    Market Share
            8.4.3.2    Historical Trend (2017-2021)
            8.4.3.3    Forecast Trend (2022-2027)
    8.5    Global Viral Inactivation Market by Application
        8.5.1    Vaccines and Therapeutics
            8.5.1.1    Market Share
            8.5.1.2    Historical Trend (2017-2021)
            8.5.1.3    Forecast Trend (2022-2027)
        8.5.2    Stem Cell Products
            8.5.2.1    Market Share
            8.5.2.2    Historical Trend (2017-2021)
            8.5.2.3    Forecast Trend (2022-2027)
        8.5.3    Blood and Blood Products
            8.5.3.1    Market Share
            8.5.3.2    Historical Trend (2017-2021)
            8.5.3.3    Forecast Trend (2022-2027)
        8.5.4    Tissue and Tissue Products
            8.5.4.1    Market Share
            8.5.4.2    Historical Trend (2017-2021)
            8.5.4.3    Forecast Trend (2022-2027)
        8.5.5    Cellular and Gene Therapy
            8.5.5.1    Market Share
            8.5.5.2    Historical Trend (2017-2021)
            8.5.5.3    Forecast Trend (2022-2027)
    8.6    Global Viral Inactivation Market by End-use
        8.6.1    Pharmaceutical and Biotechnology Companies
            8.6.1.1    Market Share
            8.6.1.2    Historical Trend (2017-2021)
            8.6.1.3    Forecast Trend (2022-2027)
        8.6.2    CROs
            8.6.2.1    Market Share
            8.6.2.2    Historical Trend (2017-2021)
            8.6.2.3    Forecast Trend (2022-2027)
        8.6.3    Academic and Research Institutes 
            8.6.3.1    Market Share
            8.6.3.2    Historical Trend (2017-2021)
            8.6.3.3    Forecast Trend (2022-2027)
        8.6.4    Others
    8.7    Global Viral Inactivation Market by Region
        8.7.1    Market Share
            8.7.1.1    North America
            8.7.1.2    Europe
            8.7.1.3    Asia Pacific
            8.7.1.4    Latin America
            8.7.1.5    Middle East and Africa
9    Regional Analysis
    9.1    North America
        9.1.1    Historical Trend (2017-2021)
        9.1.2    Forecast Trend (2022-2027)
        9.1.3    Breakup by Country
            9.1.3.1    United States of America 
            9.1.3.2    Canada
    9.2    Europe
        9.2.1    Historical Trend (2017-2021)
        9.2.2    Forecast Trend (2022-2027)
        9.2.3    Breakup by Country 
            9.2.3.1    United Kingdom
            9.2.3.2    Germany
            9.2.3.3    France
            9.2.3.4    Italy
            9.2.3.5    Others
    9.3    Asia Pacific
        9.3.1    Historical Trend (2017-2021)
        9.3.2    Forecast Trend (2022-2027)
        9.3.3    Breakup by Country
            9.3.3.1    China
            9.3.3.2    Japan
            9.3.3.3    India
            9.3.3.4    ASEAN
            9.3.3.5    Australia
            9.3.3.6    Others
    9.4    Latin America
        9.4.1    Historical Trend (2017-2021)
        9.4.2    Forecast Trend (2022-2027)
        9.4.3    Breakup by Country
            9.4.3.1    Brazil
            9.4.3.2    Argentina
            9.4.3.3    Mexico
            9.4.3.4    Others
    9.5    Middle East and Africa
        9.5.1    Historical Trend (2017-2021)
        9.5.2    Forecast Trend (2022-2027)
        9.5.3    Breakup by Country
            9.5.3.1    Saudi Arabia
            9.5.3.2    United Arab Emirates
            9.5.3.3    Nigeria
            9.5.3.4    South Africa
            9.5.3.5    Others
10    Market Dynamics
    10.1    SWOT Analysis
        10.1.1    Strengths
        10.1.2    Weaknesses
        10.1.3    Opportunities
        10.1.4    Threats
    10.2    Porter’s Five Forces Analysis
        10.2.1    Supplier’s Power
        10.2.2    Buyer’s Power
        10.2.3    Threat of New Entrants
        10.2.4    Degree of Rivalry
        10.2.5    Threat of Substitutes
    10.3    Key Indicators for Demand
    10.4    Key Indicators for Price
11    Value Chain Analysis
12    Competitive Landscape

    12.1    Market Structure
    12.2    Company Profiles
        12.2.1    Rad Source Technologies Inc
            12.2.1.1    Company Overview
            12.2.1.2    Product Portfolio
            12.2.1.3    Demographic Reach and Achievements
            12.2.1.4    Certifications
        12.2.2    Merck KGaA 
            12.2.2.1    Company Overview
            12.2.2.2    Product Portfolio
            12.2.2.3    Demographic Reach and Achievements
            12.2.2.4    Certifications
        12.2.3     Parker Hannifin Corp
            12.2.3.1    Company Overview
            12.2.3.2    Product Portfolio
            12.2.3.3    Demographic Reach and Achievements
            12.2.3.4    Certifications
        12.2.4    Sartorius AG
            12.2.4.1    Company Overview
            12.2.4.2    Product Portfolio
            12.2.4.3    Demographic Reach and Achievements
            12.2.4.4    Certifications
        12.2.5    Cerus Corporation
            12.2.5.1    Company Overview
            12.2.5.2    Product Portfolio
            12.2.5.3    Demographic Reach and Achievements
            12.2.5.4    Certifications
        12.2.6    Others
13    Industry Events and Developments

 

List of Key Figures and Tables

1.    Global Viral Inactivation Market: Key Industry Highlights, 2017 and 2027
2.    Global Viral Inactivation Historical Market: Breakup by Product (USD Million), 2017-2021
3.    Global Viral Inactivation Market Forecast: Breakup by Product (USD Million), 2022-2027
4.    Global Viral Inactivation Historical Market: Breakup by Application (USD Million), 2017-2021
5.    Global Viral Inactivation Market Forecast: Breakup by Application (USD Million), 2022-2027
6.    Global Viral Inactivation Historical Market: Breakup by End-Use (USD Million), 2017-2021
7.    Global Viral Inactivation Market Forecast: Breakup by End-Use (USD Million), 2022-2027
8.    Global Viral Inactivation Historical Market: Breakup by Region (USD Million), 2017-2021
9.    Global Viral Inactivation Market Forecast: Breakup by Region (USD Million), 2022-2027
10.    North America Viral Inactivation Historical Market: Breakup by Country (USD Million), 2017-2021
11.    North America Viral Inactivation Market Forecast: Breakup by Country (USD Million), 2022-2027
12.    Europe Viral Inactivation Historical Market: Breakup by Country (USD Million), 2017-2021
13.    Europe Viral Inactivation Market Forecast: Breakup by Country (USD Million), 2022-2027
14.    Asia Pacific Viral Inactivation Historical Market: Breakup by Country (USD Million), 2017-2021
15.    Asia Pacific Viral Inactivation Market Forecast: Breakup by Country (USD Million), 2022-2027
16.    Latin America Viral Inactivation Historical Market: Breakup by Country (USD Million), 2017-2021
17.    Latin America Viral Inactivation Market Forecast: Breakup by Country (USD Million), 2022-2027
18.    Middle East and Africa Viral Inactivation Historical Market: Breakup by Country (USD Million), 2017-2021
19.    Middle East and Africa Viral Inactivation Market Forecast: Breakup by Country (USD Million), 2022-2027
20.    Global Viral Inactivation Market Structure

Key Questions Answered in the Report

In 2021, the global viral inactivation market attained a value of nearly USD 552.33 million.

The market is projected to grow at a CAGR of 11.50% between 2022 and 2027.

The market is estimated to witness a healthy growth in the forecast period of 2022-2027 to reach about USD 1061.33 million by 2027.

The market is being driven by the increasing approvals of novel drugs, the surging use of technologically advanced processes in development of new drugs, and the robust growth of the healthcare industry.

The growing prevalence of chronic diseases, the rapid growth of the biotechnology and life sciences industry, and advancements in nano filtration technology are projected to propel the growth of the market.

The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.

The major products of viral inactivation are kits and reagents, systems, and services.

The significant applications of viral inactivation in the market are vaccines and therapeutics, stem cell products, blood and blood products, tissue and tissue products, and cellular and gene therapy.

The various end-uses in the market are pharmaceutical and biotechnology companies, CROs, and academic and research institutes, among others.

The major players in the industry are Rad Source Technologies Inc, Merck KGaA, Parker Hannifin Corp, Sartorius AG, and Cerus Corporation, among others.

Analyst Review

The global viral inactivation market attained a value of about USD 552.33 million in 2021, driven by the growing prevalence of chronic diseases. Aided by the increasing approvals of novel drugs and therapeutics, the market is expected to witness a further growth in the forecast period of 2022-2027, growing at a CAGR of 11.50%. The market is projected to reach nearly USD 1061.33 million by 2027.

EMR’s meticulous research methodology delves deep into the market, covering the macro and micro aspects of the industry. Based on product, the viral inactivation industry is categorised into kits and reagents, systems, and services. On the basis of application, the market is classified into vaccines and therapeutics, stem cell products, blood and blood products, tissue and tissue products, and cellular and gene therapy. By end-uses, the market is divided into pharmaceutical and biotechnology companies, CROs, and academic and research institutes, among others. The major regional markets for viral inactivation are North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The key players in the above market are Rad Source Technologies Inc, Merck KGaA, Parker Hannifin Corp, Sartorius AG, and Cerus Corporation, among others.

EMR’s research methodology uses a combination of cutting-edge analytical tools and the expertise of their highly accomplished team, thus, providing their customers with market insights that are accurate, actionable, and help them remain ahead of their competition.

Purchase Full Report

Mini Report

$1499
  • Selected Sections, One User
  • Printing Not Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Single User License

$2699
  • All Sections, One User
  • One Print Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Five User License

$3699
  • All Sections, Five Users
  • Five Prints Allowed
  • Email Delivery in PDF
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Corporate License

$4699
  • All Sections, Unlimited Users
  • Unlimited Prints Allowed
  • Email Delivery in PDF + Excel
  • Free Limited Customisation
  • Post Sales Analyst Support
  • 50% Discount on Next Update

Any Question? Speak With An Analyst

Contact Analyst

View A Sample

Request Sample

Did You Miss Anything, Ask Now

Request Customisation
Why Expert Market Research?

Right People

We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.

Right Methodology

We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.

Right Price

We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.

Right Support

Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.

NEWSLETTER